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ABSTRACT 
Seasonal and annual prevalence of intestinal protozoans were studied for a period of 18 years in an 
urban/suburban Los Angeles area. This is the first such study anywhere in the world. A total of 7766 fecal 
specimens from 3883 patients in the Los Angeles County, from 1996 to 2013 were tested at Parasitology 
Center, Inc. (PCI), Scottsdale, Arizona. During this period, 1629 (41%) of patients were found infected with one 
or more protozoan parasites. The most prevalent parasites were Blastocystis hominis (19%), Entamoeba 
histolytica/E. dispar (6%) E. hartmanni (6%), and Cryptosporidium parvum (5%). Blastocystis hominis made up 
45% of all infections. Infections with Blastocystis hominis progressively declined through 2013 while those of C. 
parvum increased. Infections with B. hominis were more prevalent in colder weather and lowest in August and 
September. Infections with C. parvum were most prevalent from March to June and lowest in August. The 
overall monthly prevalence for all protozoan parasites varied between 34% in August and 51% in February. The 
composition of the parasitic fauna diagnosed, annual prevalence rates, and seasonality were discussed in 
comparison with other studies.    
Key words:  Intestinal protozoans, Los Angeles, 1996-2013, Prevalence, Seasonality. 
 
INTRODUCTION 
Parasitological studies of large patient populations are rare in the United States compared 
to third-world countries where endemic parasitosis are more readily reported [1]. We, at 
the Parasitology Center, Inc. (PCI), in Scottsdale, Arizona, routinely monitor and report on 
the patterns and trends of human parasitosis in the US. The seasonal prevalence of 19 
species of intestinal parasites infecting 916 of 2,896 (32%) examined patients from 48 states 
in the year 2000 was reported [2].  In that study, 314 of 859 examined patients (36%) from 
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California were infected [2]. Infections with helminth parasites such as Ascaris lumbricoides 
and non-major protozoans were rare and are not included in the present study. The seven 
reported species of protozoan parasites constituted 91.5% of 18 species of parasites 
reported in the United States. Multiple infections with 2-4 parasitic species constituted 10% 
of the infected cases [2]. We also researched the epidemiology of Blastocystis hominis in 48 
states and the District of Columbia in 2002-2004 and included trends in annual, seasonal, 
geographical and host distribution, and symptomology by age, sex and season [3]. In that 
report, 16% of 10,582 fecal specimens from 5,291 patients tested positive for B. hominis; in 
California, 263 of 1,328 examined patients (20%) were also positive for B. hominis. In a 
similar 3-year epidemiological study of 9,856 fecal specimens from 4,928 patients from all 
states and the district of Columbia that we tested between 2003 and 2005, 279 (6%) were 
positive for Cryptosporidium parvum infections. Studies of this magnitude are not known in 
the US. Few other studies of relatively large patient populations in the US [3] [4] [5], or in 
more geographically limited populations addressing B. hominis only, e.g., California [6] or 
Ontario [7] have been reported. The present investigation is the first to cover the span of 18 
years. Evaluating the patterns and trends of parasitic infections in studies of such a long 
duration is a great tool for understanding the epidemiological characteristics, disease 
burden, improving the reporting of cases, planning prevention, therapeutic, and other 
public health measures to be considered in the management of these infections. 
Nevertheless, an overview of studies of shorter duration from comparable urban/suburban 
area in developing and developed nations are included. 
MATERIALS AND METHODS 
A total of 7766 specimens from 3883 patients (two specimens per patient) were collected, 
preserved, and transported  to Parasitology Center, Inc. (PCI) in Proto-fix ᵀᴹ (Alpha-Tec 
Systems, Inc. Vancouver, Wash.) or SAF (sodium acetate–acetic acid–formalin mixture ) in 
plastic vials provided in mailable kits. Patients were referred to PCI by 187 doctors in Los 
Angeles County from January 1996 through december 2013. The number of referring 
practitioners varied from year to year. Specimens were processed and stained with 
CONSEDᵀᴹ according to the manufacturer's (Alpha-Tec Systems) directions. This procedure 
was used in thousands of specimens at PCI, evaluated, and described previously [8].  Briefly, 
specimens are filtered, mixed with CONSED and ethyl acetate, vortexed, centrifuged, and 
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decanted.  The resulting fecal plug was mixed with CONSED diluting reagent, transferred to, 
and mounted on a slide for microscopic examination as wet mounts.  All samples were 
evaluated by the same observer blinded to patient information. The reliability of diagnosis is 
indicated by the consistency of detection of different parasites at different levels of 
infection during the same period of time. Differences in the number of patient samples 
tested in different years reflect changing patterns of patient traffic from Los Angeles County 
over time. Positive results were quantified (number of organisms per high power field on a 
scale of 1-4) from duplicate samples from each patient. About 10% of infected patients had 
2-4 parasitic species each which is the same prevalence rate of concurrent infections noted 
in our earlier study [2]. A prevalence rate based on the number of infected/examined 
patients would be about 10% lower but would not reflect the activity of individual parasitic 
species. The number of samples tested underwent a gradual decrease over the years 
corresponding to changing patterns of patients and practitioner’s traffic in the Los Angeles 
area while increasing elsewhere in the US and internationally.  
Issues in diagnosis  
We accept the possible presence of Blastocystis and Cryptosporidium organisms from 
animal sources in human infections with B. hominis and Cryptosporidium parvum as 
reviewed in Tan [9] and Garcia [10], respectively. Fletcher et al. [11] provided a 
comprehensive, well referenced diagnostic coverage of intestinal protozoan infections in 
developed countries. Human, mammalian, avian, and reptilian isolates of B. hominis have 
been assigned to 13 subtypes. Blastocystis subtype 3 is most commonly associated with 
illness in human prevalence studies. The term Blastocystis hominis normally refers to about 
10 different genetic populations that are indistinguishable microscopically. That term is used 
for parasites isolated from humans while Blastocystis spp. is used for isolations from animal 
hosts [11]. Most animals are not infected with human pathogenic cryptosporidiosis. 
However, zoonotic transmission from direct contact with infected animals or their feces 
through indirect sources including drinking of contaminated water occurs. The invasive 
Entamoeba histolytica trophozoites is less common than the morphologically identical non-
pathogenic E. dispar and E. moshkovskii but distinguishable from them by isoenzyme 
analysis. Giardia intestinalis infections are detected microscopically by us and also by 
various antigen assays demonstrating seven genetically distinct genotypes (A-G). 
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Assemblages A and B infect humans as well as other mammalian species and are considered 
zoonotic. See Fletcher et al. [11] for a discussion of above diagnostic issues.  
RESULTS 
Prevalence       
A total of 1629 parasitic infections from 3883 patients (41%) were identified between 1996-
2013 in the Los Angeles area. Blastocystis hominis was the most frequent parasitological 
finding. It was identified in 19% of samples, and represented 45% of all parasitological 
infections [Table 1]. The next most common protozoan was E. histolytica/dispar. It was 
found in 6% of samples constituting 15% of all infections. The prevalence of E. hartmanni, C. 
parvum and E.coli was 6%, 5%, and 4%, respectively. Dientamoeba fragilis and Giardia 
intestinalis were found in 4% and <1% of the samples examined, in the same order. These 
parasites constituted 91.5% of 18 species of intestinal parasites reported from 5792 fecal 
specimens tested from throughout the US in 2000 [2]. 
Annual prevalence      
The prevalence of all parasitic infections was highest during 1996-97 (63%) then gradually 
declined through 2012-2013.  Giardia intestinalis was the only protozoan that was 
consistently identified in less than 1% of tested samples throughout the study period. The 
prevalence of Cryptosporidium sp. increased and decreased cyclically reaching the lowest 
level of 2% in 1996-1997 (when other protozoans were most prevalent) to 11% in 2008-
2009 before declining again. The prevalence of B. hominis infections progressively declined 
from 21% in 1996-2001 to 7% in 2012-2013 [Table 2]. The total number of samples 
submitted from Los Angeles County was highest in 1996-1997 but declined then stabilized 
afterwards as did the total prevalence rates of all parasites.  
Seasonal prevalence      
The seasonal prevalence of all parasites was highest (43-51%) between December and 
March but lower during the rest of the year reaching a low of 34-36% in August and 
September. This pattern was clearly influenced by a corresponding pattern in the seasonal 
prevalence of B. hominis, the most common parasite, which reached 20-23% then declined 
to 13-15%, during the same time periods, respectively [Table 3]. The seasonal prevalence of 
Cryptosporidium parvum infections was more or less stable throughout the year (4-7%) but 
declined to a low of 3% in August. The prevalence of D. fragilis was highest in February (3%) 
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and November (4%). The prevalence of E. coli cysts and trophozoites was highest in July (8%) 
but lower (3-4%) between December and May. The prevalence of each of E. Hartmanni and 
E. histolytica/dispar cysts and trophozoites was highest (10%) in February and lowest (2%) in 
November. The prevalence of the amoeba trophozoites was usually relatively higher than 
that of cysts during most months. The numbers of detected G. intestinalis were too small to 
produce credible seasonal data [Table 3]. 
DISCUSSION 
Prevalence in the USA   
The overall prevalence of infection with all investigated protozoans was 41% of double fecal 
samples examined between 1996 and 2013 from 3,883 patients in the Los Angeles County. 
Infections with B. hominis made up roughly half (45%) of all protozoans studied and noted in 
Table 1. Los Angeles is an urban/suburban area and a 41% prevalence rate is markedly 
higher than the 32% and 36% prevalence rates reported earlier in the United States and 
California, respectively [2]. The testing procedures employed in this study produced a 
prevalence rate of 32.6% (3,373 infected of 10,358 examined patients throughout the 
United States) between 1996 and 1998 [8]. An almost identical prevalence of 32% was 
reported in our comprehensive study of the prevalence of intestinal parasites in 5,792 fecal 
specimens from 2,896 patients in the United States [2]. Our results reflect our most efficient 
methods of parasite detection8 which show a considerably higher prevalence rates than 
others across the country. For instance, Kappus [4] reported US prevalence of 20% (from 
216,275 stool specimens) compared with 19.7% (from 178,786 stool specimens) reported by 
state diagnostic laboratories in 1987. Similarly, Garcia and Brukner [12] reported a 
prevalence of 20.6% from 2,360 US patients. Differences in test populations or in the 
composition of the component parasite may be involved. Church et al. [5] reported a low 
prevalence of 6.4-7.2% of 2,604 fecal specimens from Colorado, Montana, New Mexico, and 
Utah were infected with parasites between August, 2006 and April, 2007. Amin reported 
19%, 50%, 39%, and 29% from the same states in the same order. Church et al. [5] 
attributed their low prevalence rates, in part, to their inability to detect infections with C. 
parvum and C. cayetanensis; Quest Diagnostics, Denver tested their specimens.  
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Prevalence in developing countries  
In comparable urban/suburban areas in Africa, Asia and South America, the prevalence of 
parasitic infections was mostly similar to ours [Table 1] but occasionally somewhat lower or 
markedly higher. It was 21.4%  of  5,990 patients in Madhya Pradesh, India [13], 23.14% of 
350 patients in Dhaka University, Bangladesh [14],  29.26%  of  287 patients in 
Muzaffaraband, Pakistan (Chaudhry et al. [15], who reviewed prevalences in 14 Pakistani 
cities from 40,096 subjects), 33% of 199 patients in Chennai, India [16], 33.4% of 1,127 
patients in Izmir, Turkey [17], 42.9% of 2,400 patients in Kumasi, Ghana [18], 47% of 293 
patients in Varamin, Iran [19], 47.2% of 1267 patients in León, Nicaragua [20], 50.5% of 93 
patients in Central Nigeria [21], 62% of 195 patients (protozoans only)  in Tamil Nadu, India 
[22], and 75.1% of 1,227 patients in Bioko, Equatorial Guinea [23]. On rare occasions, the 
overall prevalence of intestinal infection was very low reaching 5.92% of 5,743 patients in 
Eghbalieh City, Iran [24]. We believe such differences in prevalence to be attributable to 
demography, diet, environmental exposure, social habits, urbanization, and zoonotic 
relationships as can be discerned from the above articles. 
Prevalence in developed countries  
Fletcher et al. [12] summarized 33 prevalence studies from cities in developed countries, 23 
in Europe and 10 from the US, Canada, Australia, and Korea. The prevalence rate of B. 
hominis varied between 1% in Danish counties, Denmark to 16.9% in Sydney, Australia. For 
C. parvum: between 0.4% in Melbourne, Australia to 9.1% in Helsinki, Finland. For E. 
histolytica/dispar: between 0.4% in Helsinki to 3.5% in Noumea, New Caledonia. For G. 
intestinalis: between 0.3% in Melbourne, Australia to 29% in Helsinki. Entamoeba coli was 
reported only once from Brussels, Belgium at a rate of 5.4% and D. fragilis 6 times between 
0.4% in Melbourne, Australia and 14.6% in Holland.  
Prevalence of individual protozoan species  
In the United States, B. hominis was the most dominant protozoan parasite. Its reported 
prevalence was 19% (45% of all infections) [Table 1], 23% in 2000 [2], 20-30% [25], and 
12.2% [12].  It was also the most dominant parasite species reported by Kappus [4] and 
Church et al. [5] but at surprisingly lower prevalence of only 2.6% and 4.3%., respectively. In 
developed countries, B. hominis appears to also be the dominant intestinal parasite, e.g. 
Izmir, Turkey [17], Amsterdam, Holland [26] ( 24.2%), Sydney, Australia [27] (18-21%), 
Thessaloniki, Greece [28] (5.3-16.8%), Stockholm, Sweden [29] (4.0%), Berlin, Germany [30] 
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(7.6%), Helsinki, Finland [11] [Table 1; 13%], Rome, Italy [31] (7.5-14.1%), and Brussels, 
Belgium [11] [Table 1; 9.8%]. In most developing countries in Asia, Africa and South America, 
however, E. histolytica/dispar and /or G. intestinalis appear to be the dominant parasites, 
e.g., Jordan [32]; India [11] [13] [33]; Saudi Arabia [34]; Lebanon [35], Nicaragua [20], Ghana 
[18], Equatorial Guinea [23], Pakistan [15], Iran [19], and Bangladesh [14]. Fletcher et al. [11] 
concluded that “while some enteric protozoa, such as Entamoeba sp., Cryptosporidium, and 
Giardia are isolated frequently from diarrheal patients in developing regions such as Asia 
and sub-Saharan Africa, others, such as Blastocystis spp. and Dientamoeba fragilis are 
isolated mainly in developed countries.”  We concur.  
In the present study, the next highest prevalence to B. hominis were 6%, 5%, 5%, and 41.% 
noted for E. histolytica/dispar, E.hartmanni, C. parvum, and E. coli., respectively. Only 20 
patients (<1%) were infected with G. intestinalis [Table 1]. This ranking was not consistent in 
some other studies in the United States. For example, in the Rocky Mountain States, the 
prevalence of Endolimax nana and G. intestinalis ranked second (1.5%) and third (1.4%) to 
Blastocystis infections [5]. The prevalence of E. histolytica/dispar of 6% [Table 1] is markedly 
higher than the 0.9% reported in a large 1987 survey than the estimated prevalence of 4% in 
the United States [36]. The prevalence of C. parvum of 5% [Table 1] is higher than 0.6-4.3% 
reported elsewhere in North America but less than the 3-20% known from other area of the 
world (Asia, Australia, Africa, and Central and South America) [10]. Cryptosporidium parvum 
appears to be under diagnosed in the western hemisphere; its seroprevalence in Europe and 
North America is usually between 25% and 35% and may reach 64% in South America [37]. 
Cryptosporidium oocysts were observed in 27% of drinking water sampled from 66 surface 
water treatment plants in 14 states and one Canadian province [38]. Differences in the 
prevalence and composition of the intestinal parasite fauna in different geographies are 
probably attributable to demography, diet, environmental exposure, social habits, 
urbanization, and zoonotic relationships as well as to the structure of the edaphic conditions 
and weather affecting the extra-human stages of the parasites particular to each location.  
Annual prevalence  
The total number of samples submitted from the Los Angeles area was highest in 1996-1997 
but declined then stabilized afterwards corresponding with changing patterns of patient 
traffic. The prevalence of most parasitic infections was highest during 1996-97 (63%) then 
gradually declined reaching 21% in 2012-1013 agreeing with that of B. hominis, the most 
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common parasite detected, being 21% and 7%, in the same order [Table 2]. The prevalence 
of all other protozoans, except C. parvum, was highest in 1996-1997. The prevalence of C. 
parvum progressively increased from 2% in 1996-1997, when prevalence of all other 
infections were at a minimum, to a high of 11% in 2008-2009 then declined afterwards. 
Giardia intestinalis was the only protozoan that was consistently identified in 1% or less of 
the samples throughout the study period.  
Decline in annual prevalence 
The general decline in the prevalence of all parasites and especially of the dominant B. 
hominis over the years was similar to declines over time reported in other studies. In 10,582 
fecal specimens from U.S. general population [3], reported declining B. hominis prevalence 
rates of 23%, 20%, 15%, and 11% between 2000 and 2004, respectively. A similar study of C. 
parvum from 9,856 fecal specimens from US general population between 2003 and 2005 
noted an almost even prevalence of 5-6% [39].  Annual prevalence rates of microsporidiosis 
from fecal specimens of 8,550 HIV-infected patients in Southern California demonstrated a 
decline from 8.8% in 1993, 9.7% 1994, 6.6% in 1995, and 2.9% in 1996 which was attributed 
to “the use of multi-drug antiretroviral regimens and the use of protease inhibitors, a new 
class of antiretroviral agents, the first of which was licensed in 1995” [6]. In Izmir, a Turkish 
Mediterranean coastal city with a climate similar to that of Los Angeles, the prevalence of 
intestinal parasites was 42.5% in 2003 [7] and 65% five years earlier in the same area [40]. 
Of 18,563 hospital patient records studied in Qatar, the prevalence of intestinal parasites 
decreased from 13.4% in 2005-2008 to 6.6% in 2009-2011 [41]. During this period, the 
prevalence of B. hominis, G. intestinalis, and pathogenic amoeba decreased from 4.3% to 
2.9%, 1.9% to 1.4%, and 0.29% to 0.25%, respectively. This decline was attributed, in part, to 
improved screening of foreign workers. In Madhya, Pradesh, India, the prevalence of 
intestinal parasites (mostly Giardia and E. histolytica/dispar), during 2003, 2006, 2007, 2008, 
2009, 2010, and 2011 was 59.5% [42], 24.1%, 22.3%, 20.3%, 19.9%, and 20.4%, 21.4% [13], 
respectively. In Lebanon, Araj et al. [35] reported decreasing prevalence from 14% to 12% in 
E. histolytica/dispar and from 16% to 6% in G. intestinalis between 1997-1998 and 2007-
2008 in 14,771 and 7,477 fecal specimens tested, respectively. We can attribute the overall 
decline in prevalence of parasitic protozoan infections over time to improved health 
education, better preventive measures, and more effective drug therapies.    
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Seasonal prevalence 
The seasonal prevalence of all infections in our study populations did not show a dramatic 
seasonal periodicity [2] [3] [39].  However, in the present investigation, the seasonal 
prevalence of all protozoan infections was highest in February (51%) and lowest in August 
(34%) corresponding with the pattern in B. hominis [Table 3]. In 2000, we found that the 
seasonal prevalence of all infections from 48 states and the District of Columbia was highest 
in September and October (42% and 43%) and lowest in February (22%) [2]. In our studies of 
2000 [2], and 2002-2004 [3], the seasonal prevalence of B hominis in the general US 
populations also did not show any marked seasonality but was highest in September (23%) 
and lowest in February (13%). The seasonal prevalence of C. parvum in the Los Angeles area 
(this paper) was more or less stable throughout the year (3% in August to 7% in September). 
The prevalence of microsporidiosis in 8,439 fecal specimens from persons with diarrhea and 
human immunodeficiency syndrome in southern California showed no seasonal variation 
[6]. The prevalence of C. parvum from throughout the US was low (3-6%) during the colder 
months of the year (October to March) but higher during the warmer months of April and 
May, reaching 9% of 9,856 fecal specimens examined between 2003-2005 [39]. “Peaks in C. 
parvum prevalence appear to correspond with warmer seasons in temperate and tropical 
climates especially when associated with rain. During the rainy seasons, the run off from 
cattle farms readily contaminate surface waters feeding into water treatment plants as 
happened during the March-April, 1993 Milwaukee outbreak [39]. This pattern of seasonal 
waterborne fecal contamination has also been reported by other observers throughout the 
world, e.g. US [43], New Orleans [44], Peru [45], England [46], Korea [47], Uganda [48], 
Jordan [49], Guatemala [50], Indonesia [51], and Zambia [52]. Cryptosporidium infections 
from 2000 HIV-positive patients in Benin City, Nigeria were reported to also be associated 
with the rainy season [53]. The infectious stages of these soil-based intestinal parasites 
released into the environment are clearly vulnerable to seasonal variations in temperature, 
rainfall and humidity before they encounter other hosts. Transmission depends on the 
production of and host encounters with parasite stages in the environment. Seasonal 
variations in host immune system being weaker in the winter may also be involved [54].  
Seasonality of soil-based infections      
The seasonal prevalence of other soil-based infections, e.g., E. histolytica/dispar and G. 
intestinalis was also highest in the rainy season and lowest in winter or summer in 350 fecal 
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specimens tested in Dhaka University Medical Center, Bangladesh [14]. Similar results were 
reported for the same two protozoans from 23,278 fecal specimens in Qassim region of 
Saudi Arabia and from 22,970 stools in the Nablus area, Jordan by Imam et al [34]. and Ali-
Shtayeh et al. [32], respectively. Patel [33], however, reported “no significant” seasonal 
differences in the prevalence of E. histolytica/dispar, G. intestinalis, and E. coli from 36,000 
reports of inpatients and outpatients of Bombay hospital, India analyzed between 1966 and 
1975.      
Non-water sources of seasonal Cryptosporidium infections (food stuffs, drinks, animal to 
person, person to person contact, exposure to contaminated recreational water, among 
others) are known in arid desert countries mostly in the coldest season and may reach as 
high as 50% of total exposures [55]. This pattern is best illustrated in the desert country of 
Kuwait where 77% of the infections occur between November and April [56]. Seasonal 
prevalence of other protozoans investigated [Table 3] were more or less stable throughout 
the year.  
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Table 1 Prevalence of protozoan infections diagnosed from 3883 patients* examined from Los Angeles                        
County between 1996 and 2013 
Parasite species                                 Patients infected              Prevalence                        percent of infections                             
Blastocystishominis                                    732                                  19%                                     45 
Entamoeba histolytica/E.dispar**           234                                  6%                                       15 
Entamoeba hartmanni                               226                                  6%                                       14 
Cryptosporidium parvum                           201                                  5%                                       12 
Entamoeba coli**                                       156                                   4%                                       10                     
Dientamoebafragilis                                   60                                     1%                                       3                   
Giradia intestinalis**                                  20                                     0%***                                1         
Total                                                              1629*                                 41%                                  100                 
*About 10% of infected patients were concurrently infected with more than 1 species of parasite. 
**Trophozoites and cysts. 
***0% indicates values of less than 1%. 
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TABLE 2 Number and prevalence (%) of infections with major protozoan parasites diagnosed from 3883 patients examined from Los Angeles County between 
1996 and 2013 by two year period increments. 
Combined 2 year periods                  96-97           98-99           00-01           02-03            04-05            06-07            08-09           10-11           12-13 
Blastocystishominis                 315(21)*      203(21)       112(21)        29(15)        26(14)            18(9)             12(8)           9(9) 8(7) 
Cryptosporidium parvum                 30(2)       72(8)            18(3)   14(7)        14(10)            16(8)       17(11)         9(9)  6(4)                                                            
Dientamoebafragilis                 47(3)        1(0)             1(0) 1(1)         0(0)                 2(2)       1(1)             0(0) 5(5) 
Entamoeba coli cysts                 50(3)        17(2)           6(1)  3(2)          4(2)                3(1)        2(1)              1(1) 1(0) 
E.coli trophozoites                 62(4)         3(0)            4(1) 1(1)          1(1) 0(0)        0(0)              0(0) 0(0) 
E. hartmanni cysts                 89(6)         9(1)            0(0)  0(0)           1(1) 0(0)        0(0)              0(0) 1(0) 
E. hartmannitrophozoites                 122(8)        0(0)           0(0) 0(0)           1(1) 0(0)        0(0)              0(0) 0(0) 
E. histolytica/dispar cysts                 57(4)       14(1)            4(1) 1(0)            0(0)  0(0)         0(0)             1(1) 0(0) 
E. histolytica/dispartrophozoites     145(10)         12(1)            1(0) 2(1)            0(0)  0(0)                0(0)             0(0)  0(0) 
Giardia intestinalis cysts                  9(1)         5(1)            2(0)              0(0)                    0(0)              0(0)          0(0)             0(0)             0(0) 
G. intestinalis trophozoites                  1(0)**         1(0)          0(0) 0(0)             0(0) 0(0)           0(0)             0(0) 0(0) 
Total # of infections                   927          337          138               51             47  39            32                20  21 
Total examined                                  1483         947           530 193            187 195           155 92 101 
Prevalence                                  63%        36%          26% 26%             25% 20%           21% 22% 21% 
*No. of infections (% of examined patients per each 2 year period). Percentages are rounded. **0% indicates values of less than 1%.  
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TABLE 3 Seasonal distribution of  infections with major protozoan parasites diagnosed from 3883 patients examined from Los Angeles County between 1996 
and 2013.              
Parasite species                     JAN               FEB             MAR          APR           MAY           JUN           JUL           AUG           SEP          OCT          NOV      DEC      TOTAL 
Blastocystishominis                     75(23)*           72(21)         73(22)           80(20)         63(16)        62(18)        53(18)         41(13)           47(15)       58(19)       58(20)     50(20)    732(19) 
Cryptosporidium parvum           17(5)               18(5)             20(6)           16(4)  22(6)             19(6)           12(4)          9(3)                22(7) 17(6) 13(5)     16(6)     201(5) 
Dientamoebafragilis    4(1)                 11(3)              4(1)             9(2)    5(1)      4(1)               1(0)           2(1)                1(0) 7(2) 11(4)     1(0)     60(2) 
Entamoeba coli C**    6(2)           8(2)                3(1)             8(2)    8(2)       9(3)             12(4)          6(2)                 5(2) 6(2) 8(3)     6(2)       85(2) 
E. coli T**                      7(2)           3(1)                5(2)            7(2)    3(1)       6(2)              12(4)         5(2)   2(1) 8(3) 10(3)     3(1)        71(2) 
E. hartmanni C                      11(3)               13(4)              11(3)           8(2)    10(3)       10(3)             7(2)          11(4) 5(2) 5(2) 3(1)     9(4)      103(3) 
E. hartmanni T                      10(3)              20(6)              9(3) 12(3)     9(2)       10(3)              9(3)          10(3) 12(4) 8(3) 4(1)     10(4)     123(3) 
E. histolytica/dispar C    6(2)         10(3)               8(2) 2(1)     10(3)       10(3)              8(3)          4(1) 4(1) 5(2) 2(1)    6(2)     75(2) 
E. histolytica/dispar T    15(5)             24(7)               10(3) 14(4)    15(4)       19(6)              15(5)        19(6) 10(3) 6(2) 3(1)    9(4)     159(4) 
Giardia intestinalis C    2(1)        1(0)                  1(0) 3(1)    2(1)        0(0)                1(0)***    2(1) 3(1) 2(1) 0(0)   1(0)      18(0) 
G. intestinalis T                     0(0)        0(0)                 0(0) (0)0    0(0)        0(0)                 0(0)          0(0) 1(0) 0(0) 1(0)   0(0)      2(0) 
Total # of infections   153        180                    0  0    0         0               0                 0 0 0 0    0      0 
Total examined                     322        348                   333 397   386        339                 301             312 307 301 286    251      3883 
Prevalence                    47%                51%                 43%  40%    38%        43%                 43%            34% 36% 40% 39%    44%      41% 
*No. of infections (% of examined patients per each month). Percentages are rounded.     **C=cysts, T=-trophozoites.    
                                        *** 0% indicates values of less than 1%%.   
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